نتائج البحث - "Precision Medicine"

المساهمون: Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Hôpital de la Timone [CHU - APHM] (TIMONE), Marseille medical genetics - Centre de génétique médicale de Marseille (MMG), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Gustave Roussy (IGR), Biomarqueurs prédictifs et nouvelles stratégies moléculaires en thérapeutique anticancéreuse (U981), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), mamessier, emilie, Département de génétique médicale [Hôpital de la Timone - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: Genome Medicine
Genome Medicine, 2021, 13 (1), pp.87. ⟨10.1186/s13073-021-00897-9⟩
Genome Medicine, Vol 13, Iss 1, Pp 1-20 (2021)

مصطلحات موضوعية: Oncology, Male, Biopsy, QH426-470, medicine.disease_cause, Neoplasms, PERMED-01 trial, Clinical endpoint, Sequencing, Prospective Studies, Genetics (clinical), Aged, 80 and over, Comparative Genomic Hybridization, medicine.diagnostic_test, biology, Precision medicine, Disease Management, High-Throughput Nucleotide Sequencing, Genomics, Middle Aged, Prognosis, Combined Modality Therapy, Treatment Outcome, Molecular Diagnostic Techniques, Molecular Medicine, Medicine, WES, Female, KRAS, Disease Susceptibility, [SDV.IMM.IMM] Life Sciences [q-bio]/Immunology/Immunotherapy, Advanced cancers, Adult, medicine.medical_specialty, [SDV.CAN]Life Sciences [q-bio]/Cancer, Young Adult, aCGH, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, medicine, Genetics, Biomarkers, Tumor, PTEN, Humans, Molecular Biology, t-NGS, Aged, Neoplasm Staging, business.industry, Research, Cancer, Genetic Variation, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, medicine.disease, Human genetics, Clinical trial, Mutation, biology.protein, Neoplasm Grading, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6fbe58a797962887c649f4db544c93e
https://hal.science/hal-03583277

Find this article in full text from ProQuest

6

Multicenter experience with large panel next-generation sequencing in patients with advanced solid cancers in Japan

المؤلفون: Yoshiyuki Suehara, Shoji Yamanaka, Yasuhisa Terao, Haruka Hamanoue, Shigeo Yamaguchi, Kenichi Ohashi, Takuma Higurashi, Shingo Kato, Yasushi Ichikawa, Yumi Nozaki, Takuo Hayashi, Tsuyoshi Saito

المصدر: Japanese Journal of Clinical Oncology. 49:174-182

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Adolescent, Colorectal cancer, Pembrolizumab, DNA sequencing, Cohort Studies, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Japan, Neoplasms, Internal medicine, Pancreatic cancer, medicine, Humans, Radiology, Nuclear Medicine and imaging, Precision Medicine, Promoter Regions, Genetic, Aged, Neoplasm Staging, Aged, 80 and over, Gene Rearrangement, business.industry, Endometrial cancer, High-Throughput Nucleotide Sequencing, Genomics, General Medicine, medicine.disease, Precision medicine, Clinical trial, Lymphatic Metastasis, 030220 oncology & carcinogenesis, Mutation, Microsatellite, Female, Microsatellite Instability, 030211 gastroenterology & hepatology, business, Genes, Neoplasm

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2061191c9f936f3daeeebc0a07ab8e0
https://doi.org/10.1093/jjco/hyy173

7

Impact of the biomarker enrichment strategy in drug development

المؤلفون: Denis Leonardo Fontes Jardim, Leandro Jonata Carvalho Oliveira, Aline Bobato Lara Gongora

المصدر: Expert Review of Molecular Diagnostics. 20:611-618

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Time Factors, DNA Mutational Analysis, Antineoplastic Agents, Genomics, Pathology and Forensic Medicine, 03 medical and health sciences, 0302 clinical medicine, Drug Development, Meta-Analysis as Topic, Artificial Intelligence, Neoplasms, Internal medicine, Biomarkers, Tumor, Genetics, Humans, Medicine, Molecular Targeted Therapy, Precision Medicine, Personalized therapy, Drug Approval, Immune Checkpoint Inhibitors, Intersectoral Collaboration, Molecular Biology, Clinical Trials as Topic, United States Food and Drug Administration, business.industry, Patient Selection, High-Throughput Nucleotide Sequencing, Cancer, medicine.disease, United States, Clinical trial, 030104 developmental biology, Molecular Diagnostic Techniques, Drug development, Precision oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Biomarker (medicine), business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da5d1d890d8d537015b7101738264817
https://doi.org/10.1080/14737159.2020.1711734

PDF full text from Publisher

8

Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group

المساهمون: Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Prédicteurs moléculaires et nouvelles cibles en oncologie (PMNCO), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Medical Oncology

المصدر: Annals of Oncology
Annals of Oncology, Elsevier, 2020, 31, pp.1491-1505. ⟨10.1016/j.annonc.2020.07.014⟩
Annals of Oncology, 31(11), 1491-1505. Elsevier Ltd.

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, [SDV]Life Sciences [q-bio], Genomics, Pembrolizumab, Medical Oncology, DNA sequencing, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Next-generation sequencing (NGS), genomic alterations, metastatic cancers, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, Precision Medicine, Lung cancer, business.industry, High-Throughput Nucleotide Sequencing, Hematology, medicine.disease, Precision medicine, 3. Good health, Clinical trial, 030104 developmental biology, Clinical research, Drug development, 030220 oncology & carcinogenesis, business